Tag: six months

Hesai Group Reports Second Quarter 2025 Unaudited Financial Results

Quarterly net revenues were RMB706.4 million (US$98.6 million)¹Quarterly lidar shipments were 352,095 units
Quarterly net income was RMB44.1 million (US$6.2 million)

Innovative Eyewear Inc. Reports Q2 2025 Unaudited Financial Results

Revenue Surged 88% in Q2 2025 vs. Q2 2024 MIAMI, Aug. 14, 2025 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ: LUCY, LUCYW), the developer of smart eyewear...

Beam Global Announces Second Quarter 2025 Operating Results

Beam Global to Release Q2 2025 Operating Results, Conference Call Scheduled for Thursday, August 14, 2025 at 4:30 p.m. ET.

Actelis Networks Reports Second Quarter 2025 Financial Results and Operational Update

FREMONT, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today reported financial results for the second quarter ended June 30, 2025.

KORE Reports Second Quarter 2025 Results

Growth in Revenue, Adjusted EBITDA, Connections, and Free Cash Flow ATLANTA, Aug. 14, 2025 /PRNewswire/ -- KORE Group Holdings, Inc. (NYSE: KORE) ("KORE" or...

TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Completed the acquisition of Kineta, Inc. and its VISTA inhibiting monoclonal antibody (mAb), now named "TBS-2025;" planning to initiate a Phase 2 trial in...

Polar Power Reports Second Quarter 2025 Financial Results

GARDENA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Polar Power, Inc. (“Polar Power” or the “Company”) (NASDAQ: POLA), a global provider of prime, backup, and solar hybrid DC power solutions, reports its financial results for the three months ended June 30, 2025.

Tyra Biosciences Reports Second Quarter 2025 Financial Results and Highlights

- Dosed first patient in SURF302 for intermediate risk non-muscle invasive bladder cancer (IR NMIBC) - - Cash, cash equivalents, and marketable securities of $296.3...

Quantum Computing Inc. Reports Second Quarter 2025 Financial Results

HOBOKEN, N.J., Aug. 14, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today...

AmpliTech Group Advances Strategic Growth Plan with Tier 1 Customer Base Penetration in Multi-Billion Dollar 5G Markets with Record Q2 Revenues

Emmaus Life Sciences Reports Quarterly Financial Results

TORRANCE, Calif., Aug. 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell...

Cousins Maine Lobster Rolls Out Second Lubbock Truck

Local Restaurant Operator Expands Brand's Presence in Texas LUBBOCK, Texas, Aug. 14, 2025 /PRNewswire/ -- Cousins Maine Lobster (CML), the industry-leading fast-casual lobster roll brand, is...

Security National Financial Corporation Reports Financial Results for the Quarter Ended June 30, 2025

SALT LAKE CITY, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Security National Financial Corporation (SNFC) (NASDAQ symbol "SNFCA") announced financial results for the quarter ended June 30, 2025. For the three months ended June 30, 2025, SNFC’s after tax earnings decreased 10% from $7,271,000 in 2024 to $6,506,000 in 2025. For the six months ended June 30, 2025, after tax earnings decreased 26% to $10,845,000 from $14,746,000 in 2024.

Polymatech Electronics Limited Announces Completion of PCB Manufacturing Facility in Europe

CHENNAI, India, Aug. 14, 2025 /PRNewswire/ -- Polymatech Electronics Limited is thrilled to announce the successful commissioning of its state-of-the-art Printed Circuit Board (PCB) manufacturing...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsSix months

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress